Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China. (Q54434434)

29 May 2018

title

Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China. (English)

1 reference

29 May 2018

author name string

Qinghua Deng

1

1 reference

29 May 2018

Liming Sheng

2

1 reference

29 May 2018

Dan Su

3

1 reference

29 May 2018

Lizhen Zhang

4

1 reference

29 May 2018

Peng Liu

5

1 reference

29 May 2018

Ke Lu

6

1 reference

29 May 2018

Shenglin Ma

7

1 reference

29 May 2018

publication date

31 March 2010

1 reference

29 May 2018

published in

Medical Oncology

1 reference

29 May 2018

volume

28

1 reference

29 May 2018

issue

3

1 reference

29 May 2018

page(s)

667-672

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/s12032-010-9507-2

exact match

0 references

cites work

Lung cancer in never smokers: clinical epidemiology and environmental risk factors

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

The C19007T polymorphism of ERCC1 and its correlation with the risk of epithelial ovarian and endometrial cancer in Korean women. A case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

ATM missense variant P1054R predisposes to prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

ATM sequence variants associate with susceptibility to non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

Functional characterization of Ape1 variants identified in the human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

Polymorphisms in RAI and in genes of nucleotide and base excision repair are not associated with risk of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

The TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

Effect of polymorphisms in XPD, RAI, ASE-1 and ERCC1 on the risk of basal cell carcinoma among Caucasians after age 50

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9507-2

Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk

21 January 2018

1 reference

12 December 2020

Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China

1 reference

12 December 2020

ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity

1 reference

12 December 2020

A polymorphism in the APE1 gene promoter is associated with lung cancer risk

1 reference

12 December 2020

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

1 reference

12 December 2020

Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility

1 reference

12 December 2020

Contribution of mutations in ATM to breast cancer development in the Czech population

1 reference

12 December 2020

Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients

1 reference

12 December 2020

10.1007/S12032-010-9507-2

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018